DS9 Document EFTA00708569

From: To: Jeffrey Epstein <[email protected]> Subject: Fwd: Investment/Collaboration Date: Wed, 07 Jan 2015 18:06:22 +0000 Forwarded message From: LONDRE-1 < Date: Tue, Jan 6, 2015 at 11:35 AM Subject: Investment/Collaboration To: [email protected] Goff Hill Ltd. Jupiter, Florida 33477 We are seeking a collaboration with you for our antiviral drug which is very effective in destroying SSPE, and other RNA negative sense genome viruses. If the IND is confined to SSPE, it fits the orphan drug law. United States letters Patent number: 8552011 We have the medical science and treatment of RNA negative sense genome-Influenza A and B, SSPE, and polio. Viral entry of the viruses of SSPE, Influenza A and B, Polio, and measles etc. (by way of the olfactory nerve is research proven by mouse experiments which are referenced.) Most of the influenza deaths are caused by the olfactory nerve entry of the virus into the central nervous system. Goff Hill's Anti-Viral drug is given orally, is non-toxic at the dosage level required. It is effective against RNA negative sense genome-influenza A and B. polio, and measles etc. EFTA00708569 Goff Hill's Anti-Viral drug will prevent deaths and stop progressive neurologic loss. This drug is safe, non-toxic and very much needed. Using the Orphan Drug Law for SSPE, one can achieve an NDA quickly and with minimal expenses in comparison. We have a world authority on SSPE with adequate patients, who would very much like to do the study. In regards to the myelin repair, please see our neurologic anti-viral science which we have attached. This is the true repair system with clinical proven results. The anti-viral should be reviewed by Infectious disease people. We have attachments we are prepared to share with you for further review of supported evidence. In addition with a signed CDA we will present the clinical evidence and science for your review. I invite you to visit our website for more information about our drug and also about its founder, Dr. William G. Tucker. Best regards, Jennifer Londre Goff Hill Ltd. Vice President EFTA00708570